Pfizer is stopping development of its experimental oral GLP-1 drug for obesity, the company announced Monday, after a patient ...

The availability of suzetrigine may represent a critical step in addressing the nation’s pain management crisis. While questions remain about its cost, adoption, and long-term efficacy, its novel ...

The Trump administration’s plan to address the opioid crisis focuses on preventing overdose deaths, but neglects the ...

Researchers at Buffalo, N.Y.-based Roswell Park Comprehensive Cancer Center have identified an effective pain management ...